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Defining the Active Ingredients of Rehabilitation
Rehabilitation treatments and services are an
important part of the healthcare system, and
the need for such services is increasing. A larger
proportion of the population is aging or elderly
and, thanks to advances in medical technology, a
number of individuals with disability who might
previously have died are enjoying improved
survival rates.1 Rehabilitation treatments are
important both economically and in terms of
quality of life, and can be expected to become
more critical in the future.1
Despite their importance, evidence supporting the
efficacy and effectiveness of most rehabilitation
treatments is sparse. There are many reasons
for this, including inadequate funding of
rehabilitation research, insufficient numbers of
rigorously trained investigators, and the inherent
complexity of the biopsychosocial (as compared to
the biomedical) model that underlies the practice
of rehabilitation.2 However, an increasingly
recognized obstacle to research is the difficulty
in defining many rehabilitation treatments with
respect to their “active ingredients” in such a
way that their impact can be studied. Similar
to psychotherapy—whose efficacy has also
been challenging to study—most rehabilitation
treatments are delivered through some form of
interpersonal interaction between rehabilitation
therapist and patient/client, may be tailored
to the goals, strengths, and weaknesses of the
individual, and may incorporate multiple active
ingredients.3 For example, consider several
patients with difficulty walking after a stroke.
All may be receiving “gait training”, but in one
case the emphasis may be more on correcting
impaired balance; in another on clearing the
toe with each step; and another on being more
attentive to obstacles in the environment while
walking. Are these all the same treatment or is
each patient receiving a different treatment?
Because of these complexities, many attempts
at clinical rehabilitation research have resorted
to defining the treatments merely as numbers
of hours of physical, occupational, speech, and
other therapies; length of stay in a particular type
of institution; or the goal of the treatment (e.g.,
References

“attention training”), as though the actual services
delivered by clinicians and institutions during
the treatment time are unimportant. Although
numbers of sessions or hours may certainly
be relevant, just as the dose of a medication is
important, the dose does nothing to define the
active ingredients of the treatment.
Recently the National Institute on Disability
and Rehabilitation Research (NIDRR), a major
funding source for rehabilitation research,
awarded a 5-year grant to Marcel Dijkers, PhD
at Mount Sinai School of Medicine for a project
entitled, “Classification and Measurement of
Medical Rehabilitation Interventions.” This
project is intended to begin a process of building
a taxonomy of rehabilitation treatments that
is suitable for research purposes and may also
facilitate interdisciplinary communication, clinical
education, documentation, and billing. The grant
includes a subcontract to Moss Rehabilitation
Research Institute (MRRI) at the Albert Einstein
Healthcare Network, an affiliate of Thomas
Jefferson University, with John Whyte, MD, PhD
and Tessa Hart, PhD as lead investigators at MRRI.
A taxonomy is a way of dividing a set of entities—
in this case rehabilitation treatments—into a
set of ordered groups or categories. Building a
taxonomy of rehabilitation treatments that is
applicable across disabilities, treatment settings,
and patient populations is an enormous task
that cannot be completed in a single grant
cycle. The current project contains several key
activities that are expected to support ongoing
taxonomy development beyond the duration
of the project. First is the construction of a
“blueprint” for the taxonomy—an effort that will
be led by the author. The blueprint will specify
the principles by which treatments are grouped
in the final taxonomy. In principle, one could sort
rehabilitation treatments into categories according
to whether the treatment was provided by a
woman, a man, or a robot; whether the treatment
was conducted in the morning or the afternoon;
or an infinite number of other dimensions. The
development of the blueprint will be shaped by

reviewing published literature on a wide range
of rehabilitation treatments and services, paying
particular attention to overt or covert “treatment
theory,” since treatment theory proposes the
mechanism by which a treatment works. Thus,
to the extent possible, the boundaries between
treatment taxonomy categories should reflect the
active ingredients of the treatments as opposed to
dimensions that don’t bear on how the treatment
will be used or how effective it will be. Upon
completion of the blueprint, a multidisciplinary
stakeholder conference will be held to review and
critique the blueprint.
After the investigators obtain feedback from
rehabilitation professionals and consumer
advocacy groups, the blueprint will be tested by
using it to construct treatment taxonomies in
two focused areas: treatments to improve gait
and mobility for individuals with neurologic
impairments; and treatments to ameliorate
executive function deficits in individuals
with brain injury. The choice of exemplars is
relatively arbitrary and reflects a desire to assess
the blueprint’s capacity to guide organization
of a more cognitive vs. more motor domain,
and to use domains with which the research
team is particularly knowledgeable. Taxonomy
development in these two treatment areas may
suggest further refinements of the blueprint itself,
with the goal that, by the end of the five-year
project, a relatively enduring blueprint will be
published that can support further taxonomic
development in many additional treatment
areas. In the final stages of the project, the two
taxonomies discussed above and the revised
blueprint will be reviewed and critiqued by
external stakeholders, and plans made to continue
further development of a useful treatment
taxonomy for rehabilitation. 
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